Getting the flu is more than just uncomfortable—it can actually cause serious health complications (and even death) for older adults or those with pre-existing conditions such as asthma. Despite this,

AstraZeneca’s FluMist Home program officially launches today, sending nasal flu vaccines straight to people’s homes. FluMist is a flu vaccine that’s sprayed up your nose. It’s been FDA-approved since 2003, and studies show it works about as well as the traditional flu shot at preventing infections and reducing the risk of serious illness.

The FDA has approved the first at-home nasal spray flu vaccine, FluMist, allowing Americans to receive flu protection without visiting a clinic or doctor’s office.